Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Dimitrios P. Kontoyiannis, MD, MS, ScD, PhD (he/him/his)

Professor • Infectious Diseases
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center in Houston (MDACC), TX. He received his medical degree as validectorian Summa Cum Laude from the National and Kapodistrian University of Athens, Greece. Kontoyiannis was trained in Internal Medicine at Baylor College of Medicine in Houston, TX, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. He is considered one of the 1-2 leading mycology experts world-wide (expertscape.com) with an H index of 139 and 80000 citations (Google Scholar, August 4, 2025). He is the recipient of many institutional, national and international awards such as the 2004 American Society for Microbiology award for Outstanding Research in the Pathogenesis of Microbial Diseases (mentor), The Billy Cooper Memorial award from The Medical Mycology Society of Americas (MMSA, 2013), The Drouhet Medal from the European Confederation of Medical Mycology (ECMM, 2015), Littman award from the Mycology Society of NY (2016), emeritus member of Paul-Ehrlich-Society (2016), American Society for Microbiology Distinguished Lecturer, 2014-2016 the 2025 George K Daikos Lifetime Achievement Award from the Hellenic Infectious Diseases Society, the 2026 key note lecturer of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He is the recipient of the 2019 Rhoda Benham Award and the2025 Lucile George Life time Recipient award by the International Society of Human and Animal Mycology (ISHAM). Dr Kontoyiannis was awarded an honorary PhD (Honoris Causa) from the National Kapodistrian University in Athens, Greece (2017). He is a fellow of the American College of Physicians, a fellow of the Infectious Diseases Society of America (IDSA), a fellow elect of the American Academy of Microbiology, fellow of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), fellow of the Royal College of Physicians and an inaugural lifetime fellow of the ECMM. Kontoyiannis is the past president of Immunocompromised Host Society (2016-2018). He is a fellow of the American Association for the Advancement of Science (AAAS), member in class II–Medicine of the European Academy of Sciences and Arts (Academia Scientiarium et Artium Europaea) and was elected in 2023 in the American Associations of Physicians (AAP). He is the recipient of Award for Excellence in Clinical Microbiology and Infectious Diseases of ESCMID (2018). In 2023. He received the IDSA Citation Award from IDSA and the Harriet P Dustan Award for Outstanding Work in Science as Related to Medicine from ACP for 2023-2024. He is to give the Honorific Joseph E Smadel lecture in IDWeek 2025. He is the leader of the ECMM Diamond Excellence in Mycology Center at MDCC, the only US center to receive such designation by ECMM. He is the current president of the Mycoses Study Group Education Consortium (2024-2026) and cofounder of the International Society for Fungal Immunotherapy.

Disclosure(s): No financial relationships to disclose.

Presentation(s):